These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18450430)

  • 1. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.
    Bares M; Brunovsky M; Kopecek M; Novak T; Stopkova P; Kozeny J; Sos P; Krajca V; Höschl C
    Eur Psychiatry; 2008 Aug; 23(5):350-5. PubMed ID: 18450430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
    Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study.
    Bares M; Novak T; Brunovsky M; Kopecek M; Stopkova P; Krajca V; Höschl C
    J Psychiatr Res; 2012 Feb; 46(2):219-25. PubMed ID: 21937059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.
    Bares M; Brunovsky M; Kopecek M; Stopkova P; Novak T; Kozeny J; Höschl C
    J Psychiatr Res; 2007; 41(3-4):319-25. PubMed ID: 16889798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using prefrontal and midline right frontal EEG-derived theta cordance and depressive symptoms to predict the differential response or remission to antidepressant treatment in major depressive disorder.
    de la Salle S; Jaworska N; Blier P; Smith D; Knott V
    Psychiatry Res Neuroimaging; 2020 Aug; 302():111109. PubMed ID: 32480044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Krajca V; Höschl C
    Eur Neuropsychopharmacol; 2010 Jul; 20(7):459-66. PubMed ID: 20421161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.
    Hunter AM; Leuchter AF; Morgan ML; Cook IA
    Am J Psychiatry; 2006 Aug; 163(8):1426-32. PubMed ID: 16877657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early change of prefrontal theta cordance and occipital alpha asymmetry in the prediction of responses to antidepressants.
    Bares M; Novak T; Vlcek P; Hejzlar M; Brunovsky M
    Int J Psychophysiol; 2019 Sep; 143():1-8. PubMed ID: 31195067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.
    Hunter AM; Nghiem TX; Cook IA; Krantz DE; Minzenberg MJ; Leuchter AF
    Clin EEG Neurosci; 2018 Sep; 49(5):306-315. PubMed ID: 29224411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cordance derived from REM sleep EEG as a biomarker for treatment response in depression--a naturalistic study after antidepressant medication.
    Adamczyk M; Gazea M; Wollweber B; Holsboer F; Dresler M; Steiger A; Pawlowski M
    J Psychiatr Res; 2015 Apr; 63():97-104. PubMed ID: 25772006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in prefrontal activity characterize clinical responders to antidepressants.
    Cook IA; Leuchter AF; Morgan M; Witte E; Stubbeman WF; Abrams M; Rosenberg S; Uijtdehaage SH
    Neuropsychopharmacology; 2002 Jul; 27(1):120-31. PubMed ID: 12062912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in brain function of depressed subjects during treatment with placebo.
    Leuchter AF; Cook IA; Witte EA; Morgan M; Abrams M
    Am J Psychiatry; 2002 Jan; 159(1):122-9. PubMed ID: 11772700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QEEG changes during switch from depression to hypomania/mania: a case report.
    Kopecek M; Tislerova B; Sos P; Bares M; Novak T; Krajca V; Brunovsky M
    Neuro Endocrinol Lett; 2008 Jun; 29(3):295-302. PubMed ID: 18580843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal changes and treatment response prediction in depression.
    Cook IA; Leuchter AF
    Semin Clin Neuropsychiatry; 2001 Apr; 6(2):113-20. PubMed ID: 11296311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data.
    Bares M; Novak T; Kopecek M; Brunovsky M; Stopkova P; Höschl C
    Eur Arch Psychiatry Clin Neurosci; 2015 Feb; 265(1):73-82. PubMed ID: 24848366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In patients suffering from major depressive disorders, quantitative EEG showed favorable changes in left and right prefrontal cortex.
    Haghighi M; Ludyga S; Rahimi B; Jahangard L; Ahmadpanah M; Torabian S; Esnaashari F; Nazaribadie M; Bajoghli H; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    Psychiatry Res; 2017 May; 251():137-141. PubMed ID: 28199912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression.
    Hunter AM; Ravikumar S; Cook IA; Leuchter AF
    Acta Psychiatr Scand; 2009 Apr; 119(4):266-73. PubMed ID: 19077131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.
    Hunter AM; Muthén BO; Cook IA; Leuchter AF
    J Psychiatr Res; 2010 Jan; 44(2):90-8. PubMed ID: 19631948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
    Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
    Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.